Exact Sciences
EXAS
#1904
Rank
A$12.97 B
Marketcap
$69.85
Share price
-0.63%
Change (1 day)
-38.29%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Earnings for Exact Sciences (EXAS)

Earnings in 2024 (TTM): -A$1.62 Billion

According to Exact Sciences's latest financial reports the company's current earnings are A$2.75 Billion. a decrease over its 2023 earnings that were of -A$0.3 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exact Sciences from 2001 to 2024

Annual earnings

Year Earnings Change
2024 -A$1.61 Billion435.08%
2023 -A$0.3 Billion-69.28%
2022 -A$0.98 Billion-25.55%
2021 -A$1.31 Billion1.68%
2020 -A$1.29 Billion271.17%
2019 -A$0.35 Billion58.99%
2018 -A$0.22 Billion20.89%
2017 -A$0.19 Billion-30.95%
2016 -A$0.27 Billion5.09%
2015 -A$0.25 Billion57.24%
2014 -A$0.16 Billion116.53%
2013 -A$73.04 Million
2011 -A$45.47 Million143.73%
2010 -A$18.66 Million27.85%
2009 -A$14.6 Million0.27%
2008 -A$14.56 Million-20.95%
2007 -A$18.41 Million-13.53%
2006 -A$21.29 Million-10.07%
2005 -A$23.68 Million-21.81%
2004 -A$30.29 Million-33.44%
2003 -A$45.5 Million-6.51%
2002 -A$48.66 Million17.95%
2001 -A$41.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.2 Billion-88.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.10 B-106.49%๐Ÿ‡บ๐Ÿ‡ธ USA
A$40.61 M-102.54%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$55.17 Million-96.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$12.52 B-882.10%๐Ÿ‡ซ๐Ÿ‡ท France